Correction: BMC Pharmacol Toxicol 23, 81 (2022)
https://doi.org/10.1186/s40360-022-00607-0
During the publication process of the original article [1] there was an error in updating Fig. 3b and c. The correct and incorrect figure are shown in this correction article. The original publication has been updated. The publisher apologizes for the inconvenience caused to the authors & readers.
Figure 1 Incorrect figure 3 as originally published
Figure 2 correct version of figure 3
Reference
Zhang Z, et al. Dexmedetomidine alleviates inflammatory response and oxidative stress injury of vascular smooth muscle cell via α2AR/GSK-3β/MKP-1/NRF2 axis in intracranial aneurysm. BMC Pharmacol Toxicol. 2022;23:81. https://doi.org/10.1186/s40360-022-00607-0.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Zhang, Z., Mu, X. & Zhou, X. Publisher Correction to: Dexmedetomidine alleviates inflammatory response and oxidative stress injury of vascular smooth muscle cell via α2AR/GSK-3β/MKP-1/NRF2 axis in intracranial aneurysm. BMC Pharmacol Toxicol 24, 4 (2023). https://doi.org/10.1186/s40360-022-00639-6
Published:
DOI: https://doi.org/10.1186/s40360-022-00639-6